EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A semi-automated hybrid HPLC-MS approach for in-depth characterization of intact non-covalent heterodimer glycoforms of gonadotropin biopharmaceuticals

Fiammetta Di Marco, Gabriele Blümel, Constantin Blöchl, Manfred Wuhrer, Christian G Huber

Analytica Chimica Acta · 2023

DOI: 10.1016/j.aca.2023.341574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2023. Verfasst von Fiammetta Di Marco und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Medical Biology, Bioanalytical Research Labs, University of Salzburg, Hellbrunner Straße 34, 5020, Salzburg, Austria. Hauptthemen laut MEDLINE: Follicle Stimulating Hormone, Human, Biological Products. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Christian Doppler Forschungsgesellschaft, Bundesministerium für Digitalisierung und Wirtschaftsstandort.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Gonadotropins are a class of heavily glycosylated protein hormones, thus extremely challenging to characterize by mass spectrometry. As biopharmaceuticals, gonadotropins are prescribed for the treatment of infertility and are derived from different sources: either from pooled urine of pregnant women or upon production in genetically modified Chinese Hamster Ovary cells. Human chorionic gonadotropin (hCG) is sold as a biopharmaceutical under the name Pregnyl® (urinary hCG, u-hCG) and Ovitrelle® (recombinant hCG, r-hCG), and recombinant human follicle stimulating hormone (r-hFSH) is marketed as Gonal-f®. Recently, we reported the exhaustive characterization of r-hCG at different structural levels. RESULTS: We implement size exclusion (SE) HPLC-MS to automatize the acquisition of native mass spectra of r-hCG dimer, but also u-hCG and r-hFSH, comparing the drug products up to intact heterodimer level. A hybrid HPLC-MS approach was employed for the characterization of r-hCG, u-hCG and r-hFSH drug products at different structural levels. Released glycans were analyzed by porous graphitized carbon (PGC)-HPLC-MS/MS, glycopeptides by reversed-phase (RP)-HPLC-MS/MS, subunits by RP-HPLC-MS and finally the intact native heterodimers by semi-automated online buffer exchange SE-HPLC-MS. The data were integrated using bioinformatic tools, to finally unravel the composition of 1481 co-existing dimeric glycoforms for r-hCG, 1167 glycoforms for u-hCG, and 1440 glycoforms for r-hFSH, and to compare critical quality attributes of the different drug products such as their degree of sialylation and O-glycosylation. SIGNIFICANCE AND NOVELTY: The strong alliance of bioanalytics and bioinformatics data integration at the different structural levels allowed the identification of more than thousand different glycoforms of r-hCG, u-hCG, and r-hFSH. The results showed that these biopharmaceuticals differ considerably in their glycosylation patterns and highlight the importance of in-depth characterization of biopharmaceuticals for quality control. © 2017 Elsevier Inc. All rights reserved.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Follicle Stimulating Hormone, HumanBiological ProductsCricetinaeAnimalsPregnancyFemaleHumansChromatography, High Pressure LiquidTandem Mass SpectrometryCHO CellsCricetulusChorionic Gonadotropin

Stichwörter der Autor:innen

Biopharmaceutical characterizationGlycosylationGonadotropinHPLC-MSHybrid-MSIntact glycoformshCGhFSH

Substanzen

Follicle Stimulating Hormone, HumanBiological ProductsChorionic Gonadotropin

Autor:innen und Institutionen

  • Department of Biosciences and Medical Biology, Bioanalytical Research Labs, University of Salzburg, Hellbrunner Straße 34, 5020, Salzburg, Austria.
  • Department of Biosciences and Medical Biology, Bioanalytical Research Labs, University of Salzburg, Hellbrunner Straße 34, 5020, Salzburg, Austria; Center for Proteomics and Metabolomics, Leiden University Medical Cente…
  • Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.
  • Department of Biosciences and Medical Biology, Bioanalytical Research Labs, University of Salzburg, Hellbrunner Straße 34, 5020, Salzburg, Austria. Electronic address: c.huber@plus.ac.at.

Förderung

  • Austrian Science Fund
  • Christian Doppler Forschungsgesellschaft
  • Bundesministerium für Digitalisierung und Wirtschaftsstandort
  • Novartis

Zitieren

APA

Di Marco, F., Blümel, G., Blöchl, C., Wuhrer, M., & Huber, C. G. (2023). A semi-automated hybrid HPLC-MS approach for in-depth characterization of intact non-covalent heterodimer glycoforms of gonadotropin biopharmaceuticals. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2023.341574

Vancouver

Di Marco F, Blümel G, Blöchl C, Wuhrer M, Huber CG. A semi-automated hybrid HPLC-MS approach for in-depth characterization of intact non-covalent heterodimer glycoforms of gonadotropin biopharmaceuticals. Analytica Chimica Acta. 2023. doi:10.1016/j.aca.2023.341574

BibTeX
@article{DiMarco2023,
  author = {Di Marco, Fiammetta and Blümel, Gabriele and Blöchl, Constantin and Wuhrer, Manfred and Huber, Christian G},
  title = {A semi-automated hybrid HPLC-MS approach for in-depth characterization of intact non-covalent heterodimer glycoforms of gonadotropin biopharmaceuticals},
  journal = {Analytica Chimica Acta},
  year = {2023},
  doi = {10.1016/j.aca.2023.341574}
}
Kostenlos starten →